Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01685879 · ClinicalTrials.gov registry record · NA
Glycemic Response to High Amylose Rice
A NA study of Diabetes Treatment (Pilot Study), sponsored by University of Hawaii.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT01685879: Completed NA study of Diabetes Treatment (Pilot Study), sponsored by University of Hawaii.
NCT01685879 is a NA study of Diabetes Treatment (Pilot Study) that has completed, run by University of Hawaii. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01685879, a NA study of Diabetes Treatment (Pilot Study), has completed, sponsored by University of Hawaii.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
Certain types of rice have more dietary fiber than others. This type of rice is known a "high amylose rice." This study hypothesizes that high-amylose rice, will decrease blood glucose and insulin responses after consumption compared to conventional rice in healthy adults, ages 18-40. Eighteen healthy men and women will participate in this study. This study will determine how high blood glucose and insulin values rise after eating a portion of rice. This study will also evaluate hunger ratings after consuming rice. The results of this study will help researchers better understand how diet can influence diabetes management.
Primary Outcome
Evaluated changes in blood glucose after consuming a bolus of carbohydrate from rice or a standard glucose beverage.
Conditions Studied
Interventions
- OTHER Rice
- OTHER Glucose Beverage
Study Locations (1)
Hawaii
- University of Hawaii at Manoa - Honolulu
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2012-10 |
| Est. Completion | 2014-01 |
| Phase | NA |
What the finished NCT01685879 record still lists
NCT01685879 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Diabetes Treatment (Pilot Study) appearing as the primary indexed condition, and to 2 interventions - of which Rice is the first listed.
NCT01685879 reports a single indexed study location in Hawaii.
Frequently Asked Questions
What is clinical trial NCT01685879 about?
NCT01685879 is a clinical study titled "Glycemic Response to High Amylose Rice". Certain types of rice have more dietary fiber than others. This type of rice is known a "high amylose rice." This study hypothesizes that high-amylose rice, will decrease blood glucose and insulin responses after consumption compared to conventional rice in healthy adults, ages 18-40. Eighteen healt...
What is the current status of trial NCT01685879?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2012-10. Estimated completion is 2014-01.
What conditions does trial NCT01685879 study?
This clinical trial studies the following conditions: Diabetes Treatment (Pilot Study).
What interventions are being tested in trial NCT01685879?
The interventions under investigation include: Rice (OTHER), Glucose Beverage (OTHER).
Who is sponsoring clinical trial NCT01685879?
This trial is sponsored by University of Hawaii, which has 77 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01685879 being conducted?
This trial has 1 study location across Hawaii. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01685879's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia